Log in
Enquire now
‌

US Patent 9572879 ROBO2 inhibitory compositions comprising SLIT2-binding extracellular domain of ROBO2

Patent 9572879 was granted and assigned to Boston Medical Center on February, 2017 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors
Patent abstract

Provided herein are methods for the treatment of chronic kidney disease and proteinuria and for the diagnosis of chronic kidney disease and monitoring the effects of treatment on the progression of chronic kidney disease and proteinuria based on unexpected roles for the SLIT-ROBO signaling pathway in the regulation of podocyte F-actin cytoskeleton and foot process structure in the kidney.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 9572879 ROBO2 inhibitory compositions comprising SLIT2-binding extracellular domain of ROBO2

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.